alogliptin benzoate/pioglitazone HCl
12.5 mg-30 mg, 25 mg-15 mg, 25 mg-30 mg, 25 mg-45 mg — Tablet
Also known as:
OSENI
ALOGLIPTIN-PIOGLITAZONE
Coverage by Insurer
Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Blue Cross Blue Shield Federal
3 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
BCBS Federal Standard Option 2026
via alogliptin-pioglitazone |
Tier 1 - Generic | — | — | — | None |
|
BCBS Federal Basic Option 2026
via alogliptin-pioglitazone |
Tier 1 - Generic | — | — | — | None |
|
BCBS Federal Focus 2026
via alogliptin-pioglitazone |
Tier 1 - Generic | — | — | — | None |
NC Medicaid PDL
2 plansNC State Health Plan
3 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
NC State Health Plan - 80/20 Plus PPO 2026
via alogliptin-pioglitazone |
Not Covered | — | — | — | None |
|
NC State Health Plan - 70/30 Standard PPO 2026
via alogliptin-pioglitazone |
Not Covered | — | — | — | None |
|
NC State Health Plan - HDHP 2026
via alogliptin-pioglitazone |
Not Covered | — | — | — | None |